{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:37:17Z","timestamp":1789087037197,"version":"build-2803163510"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s40121-025-01251-x","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T02:53:39Z","timestamp":1761274419000},"page":"2657-2678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Targeting of Viral N-Glycosylation Modification: From Molecular Mechanisms to Clinical Application Prospects"],"prefix":"10.1007","volume":"14","author":[{"given":"Dan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9453-8188","authenticated-orcid":false,"given":"Zehong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"8045","key":"1251_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41586-024-08054-z","volume":"637","author":"TP Peacock","year":"2025","unstructured":"Peacock TP, Moncla L, Dudas G, VanInsberghe D, Sukhova K, Lloyd-Smith JO, et al. The global H5N1 influenza panzootic in mammals. Nature. 2025;637(8045):304\u201313.","journal-title":"Nature"},{"issue":"1","key":"1251_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0147-3","volume":"6","author":"ST Jacob","year":"2020","unstructured":"Jacob ST, Crozier I, Fischer WA, Hewlett A, Kraft CS, d.L. Vega M-A, et al. Ebola virus disease. Nat Rev Dis Primers. 2020;6(1):13.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"1251_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41579-024-01036-y","volume":"22","author":"JF-W Chan","year":"2024","unstructured":"Chan JF-W, Yuan S, Chu H, Sridhar S, Yuen K-Y. COVID-19 drug discovery and treatment options. Nat Rev Microbiol. 2024;22(7):391\u2013407.","journal-title":"Nat Rev Microbiol"},{"issue":"27","key":"1251_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038768","volume":"103","author":"EU Alum","year":"2024","unstructured":"Alum EU, Uti DE, Ugwu OP-C, Alum BN. Toward a cure \u2013 Advancing HIV\/AIDs treatment modalities beyond antiretroviral therapy: a review. Medicine. 2024;103(27):e38768.","journal-title":"Medicine"},{"key":"1251_CR5","doi-asserted-by":"crossref","unstructured":"S. Fauci Anthony, M. Morens David, The Perpetual Challenge of Infectious Diseases, New Engl J Med 366(5) 454\u2013461.","DOI":"10.1056\/NEJMra1108296"},{"issue":"11","key":"1251_CR6","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","volume":"5","author":"A Rambaut","year":"2020","unstructured":"Rambaut A, Holmes EC, O\u2019Toole \u00c1, Hill V, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020;5(11):1403\u20137.","journal-title":"Nat Microbiol"},{"issue":"10227","key":"1251_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0140-6736(20)30464-5","volume":"395","author":"JN Nkengasong","year":"2020","unstructured":"Nkengasong JN, Mankoula W. Looming threat of COVID-19 infection in Africa: act collectively, and fast. Lancet. 2020;395(10227):841\u20132.","journal-title":"Lancet"},{"issue":"9980","key":"1251_CR8","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/S0140-6736(15)60858-3","volume":"385","author":"DL Heymann","year":"2015","unstructured":"Heymann DL, Chen L, Takemi K, Fidler DP, Tappero JW, Thomas MJ, et al. Global health security: the wider lessons from the west African Ebola virus disease epidemic. The Lancet. 2015;385(9980):1884\u2013901.","journal-title":"The Lancet"},{"issue":"1, Supplement","key":"1251_CR9","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64(1, Supplement):S84\u2013101.","journal-title":"J Hepatol"},{"issue":"6","key":"1251_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrgastro.2016.60","volume":"13","author":"M G\u00f6tte","year":"2016","unstructured":"G\u00f6tte M, Feld JJ. Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights. Nat Rev Gastroenterol Hepatol. 2016;13(6):338\u201351.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1251_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.antiviral.2018.04.004","volume":"154","author":"KL Seley-Radtke","year":"2018","unstructured":"Seley-Radtke KL, Yates MK. The evolution of nucleoside analogue antivirals: a review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold. Antivir Res. 2018;154:66\u201386.","journal-title":"Antivir Res"},{"issue":"1","key":"1251_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2009.09.014","volume":"85","author":"T Cihlar","year":"2010","unstructured":"Cihlar T, Ray AS. Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. Antivir Res. 2010;85(1):39\u201358.","journal-title":"Antivir Res"},{"issue":"6","key":"1251_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd4010","volume":"12","author":"LP Jordheim","year":"2013","unstructured":"Jordheim LP, Durantel D, Zoulim F, Dumontet C. Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. Nat Rev Drug Discov. 2013;12(6):447\u201364.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"1251_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2165\/00003495-200363080-00004","volume":"63","author":"RS Cvetkovic","year":"2003","unstructured":"Cvetkovic RS, Goa KL. Lopinavir\/Ritonavir. Drugs. 2003;63(8):769\u2013802.","journal-title":"Drugs"},{"issue":"7","key":"1251_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073659","volume":"25","author":"B Sever","year":"2024","unstructured":"Sever B, Otsuka M, Fujita M, Ciftci H. A review of FDA-approved anti-HIV-1 drugs, anti-Gag compounds, and potential strategies for HIV-1 eradication. Int J Mol Sci. 2024;25(7):3659.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1251_CR16","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.3390\/v7122968","volume":"7","author":"A Ahmed","year":"2015","unstructured":"Ahmed A, Felmlee DJ. Mechanisms of hepatitis C viral resistance to direct acting antivirals. Viruses. 2015;7(12):6716\u201329.","journal-title":"Viruses"},{"issue":"2","key":"1251_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.antiviral.2013.09.020","volume":"100","author":"JM Baugh","year":"2013","unstructured":"Baugh JM, Garcia-Rivera JA, Gallay PA. Host-targeting agents in the treatment of hepatitis C: a beginning and an end? Antivir Res. 2013;100(2):555\u201361.","journal-title":"Antivir Res"},{"key":"1251_CR18","doi-asserted-by":"crossref","unstructured":"N. Kumar, S. Sharma, R. Kumar, N. Tripathi Bhupendra, S. Barua, H. Ly, T. Rouse Barry, Host-directed antiviral therapy, Clinical Microbiology Reviews 33(3) (2020) e00168\u201319.","DOI":"10.1128\/CMR.00168-19"},{"issue":"1","key":"1251_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-021-00809-8","volume":"6","author":"Y Gong","year":"2021","unstructured":"Gong Y, Qin S, Dai L, Tian Z. The glycosylation in SARS-CoV-2 and its receptor ACE2. Signal Transduct Target Ther. 2021;6(1):396.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"1251_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/glycob\/cwy021","volume":"28","author":"I Bagdonaite","year":"2018","unstructured":"Bagdonaite I, Wandall HH. Global aspects of viral glycosylation. Glycobiology. 2018;28(7):443\u201367.","journal-title":"Glycobiology"},{"key":"1251_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115196","volume":"166","author":"M Gorzkiewicz","year":"2023","unstructured":"Gorzkiewicz M, Cramer J, Xu HC, Lang PA. The role of glycosylation patterns of viral glycoproteins and cell entry receptors in arenavirus infection. Biomed Pharmacother. 2023;166:115196.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1251_CR22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/21505594.2022.2060464","volume":"13","author":"T Feng","year":"2022","unstructured":"Feng T, Jinyu Z, Zhiqian C, Wen P, Zhengrong C, Yongdong Y, et al. Glycosylation of viral proteins: implication in virus\u2013host interaction and virulence. Virulence. 2022;13(1):670\u201383.","journal-title":"Virulence"},{"issue":"10","key":"1251_CR23","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","volume":"1863","author":"Y Watanabe","year":"2019","unstructured":"Watanabe Y, Bowden TA, Wilson IA, Crispin M. Exploitation of glycosylation in enveloped virus pathobiology. Biochimica et Biophysica Acta (BBA) - General Subjects. 2019;1863(10):1480\u201397.","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"issue":"5","key":"1251_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tim.2007.03.003","volume":"15","author":"DJ Vigerust","year":"2007","unstructured":"Vigerust DJ, Shepherd VL. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 2007;15(5):211\u20138.","journal-title":"Trends Microbiol"},{"issue":"1","key":"1251_CR25","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171505","volume":"39","author":"IA York","year":"2019","unstructured":"York IA, Stevens J, Alymova IV. Influenza virus N-linked glycosylation and innate immunity. Biosci Rep. 2019;39(1):BSR20171505.","journal-title":"Biosci Rep"},{"issue":"8","key":"1251_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrmicro1707","volume":"5","author":"J Balzarini","year":"2007","unstructured":"Balzarini J. Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat Rev Microbiol. 2007;5(8):583\u201397.","journal-title":"Nat Rev Microbiol"},{"key":"1251_CR27","first-page":"273","volume-title":"Swine Influenza","author":"EA Govorkova","year":"2013","unstructured":"Govorkova EA, McCullers JA. Therapeutics Against Influenza. In: Richt JA, Webby RJ, editors. Swine Influenza. Berlin Heidelberg, Berlin, Heidelberg: Springer; 2013. p. 273\u2013300."},{"key":"1251_CR28","first-page":"165","volume-title":"Genomics and Systems Biology of Mammalian Cell Culture","author":"M Berger","year":"2012","unstructured":"Berger M, Kaup M, Blanchard V. Protein Glycosylation and Its Impact on Biotechnology. In: Hu WS, Zeng A-P, editors. Genomics and Systems Biology of Mammalian Cell Culture. Berlin Heidelberg, Berlin, Heidelberg: Springer; 2012. p. 165\u201385."},{"issue":"1","key":"1251_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05000-5","volume":"22","author":"K Garapati","year":"2024","unstructured":"Garapati K, Jain A, Madden BJ, Mun D-G, Sharma J, Budhraja R, et al. Defining albumin as a glycoprotein with multiple N-linked glycosylation sites. J Transl Med. 2024;22(1):454.","journal-title":"J Transl Med"},{"issue":"1","key":"1251_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58740-3","volume":"16","author":"Y Huang","year":"2025","unstructured":"Huang Y, Zhong W-Q, Yang X-Y, Shan J-L, Zhou L, Li Z-L, et al. Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity. Nat Commun. 2025;16(1):3546.","journal-title":"Nat Commun"},{"issue":"47","key":"1251_CR31","doi-asserted-by":"publisher","first-page":"29595","DOI":"10.1073\/pnas.2013620117","volume":"117","author":"\u0141F Sobala","year":"2020","unstructured":"Sobala \u0141F, Fernandes PZ, Hakki Z, Thompson AJ, Howe JD, Hill M, et al. Structure of human endo-\u03b1-1,2-mannosidase (MANEA), an antiviral host-glycosylation target. Proc Natl Acad Sci U S A. 2020;117(47):29595\u2013601.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1251_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2021.151186","volume":"100","author":"S Esmail","year":"2021","unstructured":"Esmail S, Manolson MF. Advances in understanding N-glycosylation structure, function, and regulation in health and disease. Eur J Cell Biol. 2021;100(7):151186.","journal-title":"Eur J Cell Biol"},{"issue":"7696","key":"1251_CR33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature25755","volume":"555","author":"L Bai","year":"2018","unstructured":"Bai L, Wang T, Zhao G, Kovach A, Li H. The atomic structure of a eukaryotic oligosaccharyltransferase complex. Nature. 2018;555(7696):328\u201333.","journal-title":"Nature"},{"issue":"4","key":"1251_CR34","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s10545-011-9337-1","volume":"34","author":"E Mohorko","year":"2011","unstructured":"Mohorko E, Glockshuber R, Aebi M. Oligosaccharyltransferase: the central enzyme of N-linked protein glycosylation. J Inherit Metab Dis. 2011;34(4):869\u201378.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"1251_CR35","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/biom10040624","volume":"10","author":"S Mohanty","year":"2020","unstructured":"Mohanty S, Chaudhary BP, Zoetewey D. Structural insight into the mechanism of N-linked glycosylation by oligosaccharyltransferase. Biomolecules. 2020;10(4):624.","journal-title":"Biomolecules"},{"issue":"4","key":"1251_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a005199","volume":"3","author":"P Stanley","year":"2011","unstructured":"Stanley P. Golgi glycosylation. Cold Spring Harb Perspect Biol. 2011;3(4):a005199.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"12","key":"1251_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122652","volume":"9","author":"A Frappaolo","year":"2020","unstructured":"Frappaolo A, Karimpour-Ghahnavieh A, Sechi S, Giansanti MG. The close relationship between the Golgi trafficking machinery and protein glycosylation. Cells. 2020;9(12):2652.","journal-title":"Cells"},{"issue":"5","key":"1251_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/jb\/mvi068","volume":"137","author":"S-I Nishikawa","year":"2005","unstructured":"Nishikawa S-I, Brodsky JL, Nakatsukasa K. Roles of molecular chaperones in Endoplasmic Reticulum (ER) quality control and ER-associated degradation (ERAD). J Biochem. 2005;137(5):551\u20135.","journal-title":"J Biochem"},{"issue":"4","key":"1251_CR39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ceb.2004.06.012","volume":"16","author":"B Kleizen","year":"2004","unstructured":"Kleizen B, Braakman I. Protein folding and quality control in the endoplasmic reticulum. Curr Opin Cell Biol. 2004;16(4):343\u20139.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"1251_CR40","doi-asserted-by":"publisher","first-page":"20575","DOI":"10.1038\/srep20575","volume":"6","author":"T Satoh","year":"2016","unstructured":"Satoh T, Toshimori T, Yan G, Yamaguchi T, Kato K. Structural basis for two-step glucose trimming by glucosidase II involved in ER glycoprotein quality control. Sci Rep. 2016;6(1):20575.","journal-title":"Sci Rep"},{"key":"1251_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.semcdb.2014.11.006","volume":"41","author":"R Benyair","year":"2015","unstructured":"Benyair R, Ogen-Shtern N, Lederkremer GZ. Glycan regulation of ER-associated degradation through compartmentalization. Semin Cell Dev Biol. 2015;41:99\u2013109.","journal-title":"Semin Cell Dev Biol"},{"issue":"22","key":"1251_CR42","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1016\/j.febslet.2015.07.021","volume":"589","author":"JJ Caramelo","year":"2015","unstructured":"Caramelo JJ, Parodi AJ. A sweet code for glycoprotein folding. FEBS Lett. 2015;589(22):3379\u201387.","journal-title":"FEBS Lett"},{"key":"1251_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcdb.2014.12.001","volume":"41","author":"A Tannous","year":"2015","unstructured":"Tannous A, Pisoni GB, Hebert DN, Molinari M. N-linked sugar-regulated protein folding and quality control in the ER. Semin Cell Dev Biol. 2015;41:79\u201389.","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"1251_CR44","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1073\/pnas.91.3.913","volume":"91","author":"C Hammond","year":"1994","unstructured":"Hammond C, Braakman I, Helenius A. Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc Natl Acad Sci U S A. 1994;91(3):913\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1251_CR45","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/74035","volume":"7","author":"C Ritter","year":"2000","unstructured":"Ritter C, Helenius A. Recognition of local glycoprotein misfolding by the ER folding sensor UDP-glucose:glycoprotein glucosyltransferase. Nat Struct Biol. 2000;7(4):278\u201380.","journal-title":"Nat Struct Biol"},{"key":"1251_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.carres.2021.108273","volume":"502","author":"T Kuribara","year":"2021","unstructured":"Kuribara T, Usui R, Totani K. Glycan structure-based perspectives on the entry and release of glycoproteins in the calnexin\/calreticulin cycle. Carbohydr Res. 2021;502:108273.","journal-title":"Carbohydr Res"},{"issue":"4","key":"1251_CR47","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/tra.12358","volume":"17","author":"L Lamriben","year":"2016","unstructured":"Lamriben L, Graham JB, Adams BM, Hebert DN. N-glycan-based ER molecular chaperone and protein quality control system: the calnexin binding cycle. Traffic. 2016;17(4):308\u201326.","journal-title":"Traffic"},{"issue":"1","key":"1251_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3480001","volume":"348","author":"AJ Parodi","year":"2000","unstructured":"Parodi AJ. Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem J. 2000;348(1):1\u201313.","journal-title":"Biochem J"},{"issue":"16","key":"1251_CR49","doi-asserted-by":"publisher","first-page":"10221","DOI":"10.1074\/jbc.R700048200","volume":"283","author":"JJ Caramelo","year":"2008","unstructured":"Caramelo JJ, Parodi AJ. Getting in and out from Calnexin\/Calreticulin cycles. J Biol Chem. 2008;283(16):10221\u20135.","journal-title":"J Biol Chem"},{"key":"1251_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2020.598552","volume":"11","author":"H Du","year":"2021","unstructured":"Du H, Zheng C, Aslam M, Xie X, Wang W, Yang Y, et al. Endoplasmic reticulum-mediated protein quality control and endoplasmic reticulum-associated degradation pathway explain the reduction of N-glycoprotein level under the lead stress. Front Plant Sci. 2021;11:598552.","journal-title":"Front Plant Sci"},{"issue":"3","key":"1251_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1385\/CBB:39:3:223","volume":"39","author":"L Ellgaard","year":"2003","unstructured":"Ellgaard L, Frickel E-M. Calnexin, calreticulin, and ERp57. Cell Biochem Biophys. 2003;39(3):223\u201347.","journal-title":"Cell Biochem Biophys"},{"issue":"5296","key":"1251_CR52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.275.5296.86","volume":"275","author":"JD Oliver","year":"1997","unstructured":"Oliver JD, van der Wal FJ, Bulleid NJ, High S. Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science. 1997;275(5296):86\u20138.","journal-title":"Science"},{"key":"1251_CR53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.coviro.2019.05.003","volume":"36","author":"AA Hargett","year":"2019","unstructured":"Hargett AA, Renfrow MB. Glycosylation of viral surface proteins probed by mass spectrometry. Curr Opin Virol. 2019;36:56\u201366.","journal-title":"Curr Opin Virol"},{"issue":"29","key":"1251_CR54","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.1007\/s00216-021-03499-x","volume":"413","author":"A Shajahan","year":"2021","unstructured":"Shajahan A, Pepi LE, Rouhani DS, Heiss C, Azadi P. Glycosylation of SARS-CoV-2: structural and functional insights. Anal Bioanal Chem. 2021;413(29):7179\u201393.","journal-title":"Anal Bioanal Chem"},{"key":"1251_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.122402","volume":"342","author":"A Lembo","year":"2024","unstructured":"Lembo A, Molinaro A, De Castro C, Berti F, Biagini M. Impact of glycosylation on viral vaccines. Carbohydr Polym. 2024;342:122402.","journal-title":"Carbohydr Polym"},{"issue":"14","key":"1251_CR56","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1042\/BCJ20170111","volume":"474","author":"NG Jayaprakash","year":"2017","unstructured":"Jayaprakash NG, Surolia A. Role of glycosylation in nucleating protein folding and stability. Biochem J. 2017;474(14):2333\u201347.","journal-title":"Biochem J"},{"issue":"3","key":"1251_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgac085","volume":"1","author":"H Sun","year":"2022","unstructured":"Sun H, Deng G, Sun H, Song J, Zhang W, Li H, et al. N-linked glycosylation enhances hemagglutinin stability in avian H5N6 influenza virus to promote adaptation in mammals. PNAS Nexus. 2022;1(3):pgac085.","journal-title":"PNAS Nexus"},{"key":"1251_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638573","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Liu D, Wang Y, Su W, Liu G, Dong W. The importance of glycans of viral and host proteins in enveloped virus infection. Front Immunol. 2021;12:638573.","journal-title":"Front Immunol"},{"issue":"4","key":"1251_CR59","doi-asserted-by":"publisher","first-page":"e01549","DOI":"10.1128\/jvi.01549-21","volume":"96","author":"M Xu","year":"2022","unstructured":"Xu M, Qian K, Shao H, Yao Y, Nair V, Ye J, et al. Glycosylation of ALV-J Envelope Protein at Sites 17 and 193 Is Pivotal in the Virus Infection. J Virol. 2022;96(4):e01549-e1621.","journal-title":"J Virol"},{"key":"1251_CR60","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3389\/fimmu.2020.01450","volume":"11","author":"J Mellors","year":"2020","unstructured":"Mellors J, Tipton T, Longet S, Carroll M. Viral evasion of the complement system and its importance for vaccines and therapeutics. Front Immunol. 2020;11:1450.","journal-title":"Front Immunol"},{"issue":"3","key":"1251_CR61","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/v6031294","volume":"6","author":"MD Tate","year":"2014","unstructured":"Tate MD, Job ER, Deng Y-M, Gunalan V, Maurer-Stroh S, Reading PC. Playing hide and seek: how glycosylation of the Influenza virus hemagglutinin can modulate the immune response to infection. Viruses. 2014;6(3):1294\u2013316.","journal-title":"Viruses"},{"issue":"19","key":"1251_CR62","doi-asserted-by":"publisher","first-page":"9586","DOI":"10.1128\/JVI.00141-06","volume":"80","author":"M Sagar","year":"2006","unstructured":"Sagar M, Wu X, Lee S, Overbaugh J. Human immunodeficiency virus type 1 V1\u2013V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J Virol. 2006;80(19):9586\u201398.","journal-title":"J Virol"},{"issue":"3","key":"1251_CR63","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00430-006-0016-z","volume":"195","author":"T Wolk","year":"2006","unstructured":"Wolk T, Schreiber M. N-glycans in the gp120 V1\/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization. Med Microbiol Immunol. 2006;195(3):165\u201372.","journal-title":"Med Microbiol Immunol"},{"issue":"3","key":"1251_CR64","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nm0397-338","volume":"3","author":"NL Michael","year":"1997","unstructured":"Michael NL, Chang G, Loum LG, Mascola JR, Dondero D, Birx DL, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med. 1997;3(3):338\u201340.","journal-title":"Nat Med"},{"issue":"15","key":"1251_CR65","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1073\/pnas.84.15.5424","volume":"84","author":"TJ Matthews","year":"1987","unstructured":"Matthews TJ, Weinhold KJ, Lyerly HK, Langlois AJ, Wigzell H, Bolognesi DP. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci U S A. 1987;84(15):5424\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1251_CR66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0168-1702(90)90085-P","volume":"18","author":"L Dirckx","year":"1990","unstructured":"Dirckx L, Lindemann D, Ette R, Manzoni C, Moritz D, Mous J. Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity. Virus Res. 1990;18(1):9\u201320.","journal-title":"Virus Res"},{"issue":"2","key":"1251_CR67","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.vetmic.2014.12.011","volume":"175","author":"X Zhang","year":"2015","unstructured":"Zhang X, Chen S, Jiang Y, Huang K, Huang J, Yang D, et al. Hemagglutinin glycosylation modulates the pathogenicity and antigenicity of the H5N1 avian influenza virus. Vet Microbiol. 2015;175(2):244\u201356.","journal-title":"Vet Microbiol"},{"key":"1251_CR68","doi-asserted-by":"crossref","unstructured":"W. Wang, B. Lu, H. Zhou, L. Suguitan Amorsolo, X. Cheng, K. Subbarao, G. Kemble, H. Jin, Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A\/Vietnam\/1203\/2004 vaccine virus in ferrets, Journal of Virology 84(13) (2010) 6570\u20136577.","DOI":"10.1128\/JVI.00221-10"},{"key":"1251_CR69","doi-asserted-by":"crossref","unstructured":"D. Wen, S. Li, F. Dong, Y. Zhang, Y. Lin, J. Wang, Z. Zou, A. Zheng, N-glycosylation of viral E protein is the determinant for vector midgut invasion by flaviviruses, mBio 9(1) (2018) e00046\u201318.","DOI":"10.1128\/mBio.00046-18"},{"key":"1251_CR70","doi-asserted-by":"crossref","unstructured":"J. Lennemann Nicholas, A. Rhein Bethany, E. Ndungo, K. Chandran, X. Qiu, W. Maury, Comprehensive functional analysis of N-linked glycans on Ebola virus GP1, mBio 5(1) (2014) e00862\u201313.","DOI":"10.1128\/mBio.00862-13"},{"key":"1251_CR71","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.vetmic.2018.03.018","volume":"217","author":"R Gao","year":"2018","unstructured":"Gao R, Gu M, Liu K, Li Q, Li J, Shi L, et al. T160a mutation-induced deglycosylation at site 158 in hemagglutinin is a critical determinant of the dual receptor binding properties of clade 2.3.4.4 H5NX subtype avian influenza viruses. Vet Microbiol. 2018;217:158\u201366.","journal-title":"Vet Microbiol"},{"issue":"1","key":"1251_CR72","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13567-020-00879-6","volume":"52","author":"R Gao","year":"2021","unstructured":"Gao R, Gu M, Shi L, Liu K, Li X, Wang X, et al. N-linked glycosylation at site 158 of the HA protein of H5N6 highly pathogenic avian influenza virus is important for viral biological properties and host immune responses. Vet Res. 2021;52(1):8.","journal-title":"Vet Res"},{"key":"1251_CR73","doi-asserted-by":"crossref","unstructured":"Y. Li, D. Liu, Y. Wang, W. Su, G. Liu, W. Dong, The Importance of Glycans of Viral and Host Proteins in Enveloped Virus Infection, Frontiers in Immunology Volume 12 - 2021 (2021).","DOI":"10.3389\/fimmu.2021.638573"},{"issue":"2","key":"1251_CR74","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","volume":"411","author":"JS Rossman","year":"2011","unstructured":"Rossman JS, Lamb RA. Influenza virus assembly and budding. Virology. 2011;411(2):229\u201336.","journal-title":"Virology"},{"issue":"35","key":"1251_CR75","doi-asserted-by":"publisher","first-page":"21473","DOI":"10.1074\/jbc.M115.637363","volume":"290","author":"N Altg\u00e4rde","year":"2015","unstructured":"Altg\u00e4rde N, Eriksson C, Peerboom N, Phan-Xuan T, Moeller S, Schnabelrauch M, et al. Mucin-like region of Herpes Simplex Virus Type 1 attachment protein glycoprotein C (gC) modulates the virus-glycosaminoglycan interaction*. J Biol Chem. 2015;290(35):21473\u201385.","journal-title":"J Biol Chem"},{"key":"1251_CR76","doi-asserted-by":"crossref","unstructured":"L. Hanna Sheri, C. Pierson Theodore, D. Sanchez Melissa, A. Ahmed Asim, M. Murtadha Mariam, W. Doms Robert, N-linked glycosylation of west Nile virus envelope proteins influences particle assembly and infectivity, Journal of Virology 79(21) (2005) 13262\u201313274.","DOI":"10.1128\/JVI.79.21.13262-13274.2005"},{"issue":"2","key":"1251_CR77","doi-asserted-by":"publisher","first-page":"29R","DOI":"10.1093\/glycob\/cwj016","volume":"16","author":"C Breton","year":"2006","unstructured":"Breton C, \u0160najdrov\u00e1 L, Jeanneau C, Ko\u010da J, Imberty A. Structures and mechanisms of glycosyltransferases. Glycobiology. 2006;16(2):29R-37R.","journal-title":"Glycobiology"},{"issue":"31","key":"1251_CR78","doi-asserted-by":"publisher","first-page":"27038","DOI":"10.1021\/acsomega.2c02345","volume":"7","author":"N Tripathi","year":"2022","unstructured":"Tripathi N, Goel B, Bhardwaj N, Vishwakarma RA, Jain SK. Exploring the potential of chemical inhibitors for targeting post-translational glycosylation of coronavirus (SARS-CoV-2). ACS Omega. 2022;7(31):27038\u201351.","journal-title":"ACS Omega"},{"issue":"23","key":"1251_CR79","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01443-19","volume":"93","author":"S Zhu","year":"2019","unstructured":"Zhu S, Wan W, Zhang Y, Shang W, Pan X, Zhang L-K, et al. Comprehensive interactome analysis reveals that STT3B is required for N-glycosylation of Lassa virus glycoprotein. J Virol. 2019;93(23):e01443\u201319.","journal-title":"J Virol"},{"issue":"7","key":"1251_CR80","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/glycob\/cwv018","volume":"25","author":"S Shrimal","year":"2015","unstructured":"Shrimal S, Gilmore R. Reduced expression of the oligosaccharyltransferase exacerbates protein hypoglycosylation in cells lacking the fully assembled oligosaccharide donor. Glycobiology. 2015;25(7):774\u201383.","journal-title":"Glycobiology"},{"key":"1251_CR81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ceb.2016.03.021","volume":"41","author":"N Cherepanova","year":"2016","unstructured":"Cherepanova N, Shrimal S, Gilmore R. N-linked glycosylation and homeostasis of the endoplasmic reticulum. Curr Opin Cell Biol. 2016;41:57\u201365.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"1251_CR82","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41421-021-00354-2","volume":"7","author":"Y-J Huang","year":"2021","unstructured":"Huang Y-J, Zhao H, Huang X, Deng Y-Q, Li X-F, Ye Q, et al. Identification of oligosaccharyltransferase as a host target for inhibition of SARS-CoV-2 and its variants. Cell Discov. 2021;7(1):116.","journal-title":"Cell Discov"},{"issue":"11","key":"1251_CR83","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1016\/j.celrep.2017.11.054","volume":"21","author":"AS Puschnik","year":"2017","unstructured":"Puschnik AS, Marceau CD, Ooi YS, Majzoub K, Rinis N, Contessa JN, et al. A small-molecule oligosaccharyltransferase inhibitor with pan-flaviviral activity. Cell Rep. 2017;21(11):3032\u20139.","journal-title":"Cell Rep"},{"issue":"3","key":"1251_CR84","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41594-018-0031-y","volume":"25","author":"J Yoo","year":"2018","unstructured":"Yoo J, Mashalidis EH, Kuk ACY, Yamamoto K, Kaeser B, Ichikawa S, et al. GlcNAc-1-P-transferase\u2013tunicamycin complex structure reveals basis for inhibition of N-glycosylation. Nat Struct Mol Biol. 2018;25(3):217\u201324.","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"1251_CR85","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171641","volume":"38","author":"S-P Jin","year":"2018","unstructured":"Jin S-P, Chung JH. Inhibition of N-glycosylation by tunicamycin attenuates cell\u2013cell adhesion via impaired desmosome formation in normal human epidermal keratinocytes. Biosci Rep. 2018;38(6):BSR20171641.","journal-title":"Biosci Rep"},{"key":"1251_CR86","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/B978-0-12-409547-2.14698-0","volume-title":"Comprehensive Natural Products III","author":"J Zhang","year":"2020","unstructured":"Zhang J, Fan P-H, Lin G-M, Chang W-C, Liu H-W. 2.14 - Recent Progress in Unusual Carbohydrate-Containing Natural Products Biosynthesis. In: Liu H-W, Begley TP, editors. Comprehensive Natural Products III. Oxford: Elsevier; 2020. p. 336\u201392."},{"key":"1251_CR87","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejmech.2017.05.051","volume":"137","author":"G Pastuch-Gawolek","year":"2017","unstructured":"Pastuch-Gawolek G, Chaubey B, Szewczyk B, Krol E. Novel thioglycosyl analogs of glycosyltransferase substrates as antiviral compounds against classical swine fever virus and hepatitis C virus. Eur J Med Chem. 2017;137:247\u201362.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"1251_CR88","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tibs.2009.10.001","volume":"35","author":"M Aebi","year":"2010","unstructured":"Aebi M, Bernasconi R, Clerc S, Molinari M. N-glycan structures: recognition and processing in the ER. Trends Biochem Sci. 2010;35(2):74\u201382.","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"1251_CR89","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.antiviral.2013.03.023","volume":"98","author":"J Chang","year":"2013","unstructured":"Chang J, Warren TK, Zhao X, Gill T, Guo F, Wang L, et al. Small molecule inhibitors of ER \u03b1-glucosidases are active against multiple hemorrhagic fever viruses. Antivir Res. 2013;98(3):432\u201340.","journal-title":"Antivir Res"},{"issue":"6","key":"1251_CR90","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.semcdb.2007.09.007","volume":"18","author":"K Kanehara","year":"2007","unstructured":"Kanehara K, Kawaguchi S, Ng DTW. The EDEM and Yos9p families of lectin-like ERAD factors. Semin Cell Dev Biol. 2007;18(6):743\u201350.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"1251_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14954","volume":"8","author":"L Cao","year":"2017","unstructured":"Cao L, Diedrich JK, Kulp DW, Pauthner M, He L, Park S-KR, et al. Global site-specific N-glycosylation analysis of HIV envelope glycoprotein. Nat Commun. 2017;8(1):14954.","journal-title":"Nat Commun"},{"issue":"1","key":"1251_CR92","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1742-6405-11-23","volume":"11","author":"M Raska","year":"2014","unstructured":"Raska M, Czernekova L, Moldoveanu Z, Zachova K, Elliott MC, Novak Z, et al. Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection. AIDS Res Ther. 2014;11(1):23.","journal-title":"AIDS Res Ther"},{"issue":"6","key":"1251_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130621","volume":"10","author":"L Mathys","year":"2015","unstructured":"Mathys L, Balzarini J. Several N-glycans on the HIV envelope glycoprotein gp120 preferentially locate near disulphide bridges and are required for efficient infectivity and virus transmission. PLoS ONE. 2015;10(6):e0130621.","journal-title":"PLoS ONE"},{"issue":"6143","key":"1251_CR94","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/330074a0","volume":"330","author":"RA Gruters","year":"1987","unstructured":"Gruters RA, Neefjes JJ, Tersmette M, de Goede REY, Tulp A, Huisman HG, et al. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature. 1987;330(6143):74\u20137.","journal-title":"Nature"},{"issue":"10","key":"1251_CR95","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.1128\/jvi.70.10.7143-7152.1996","volume":"70","author":"PB Fischer","year":"1996","unstructured":"Fischer PB, Karlsson GB, Butters TD, Dwek RA, Platt FM. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1\/V2 region of gp120. J Virol. 1996;70(10):7143\u201352.","journal-title":"J Virol"},{"issue":"10","key":"1251_CR96","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1128\/jvi.70.10.7153-7160.1996","volume":"70","author":"PB Fischer","year":"1996","unstructured":"Fischer PB, Karlsson GB, Dwek RA, Platt FM. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure. J Virol. 1996;70(10):7153\u201360.","journal-title":"J Virol"},{"issue":"5","key":"1251_CR97","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1073\/pnas.94.5.1822","volume":"94","author":"A Mehta","year":"1997","unstructured":"Mehta A, Lu X, Block TM, Blumberg BS, Dwek RA. Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. Proc Natl Acad Sci U S A. 1997;94(5):1822\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1251_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061404","volume":"9","author":"MO Dobrica","year":"2020","unstructured":"Dobrica MO, Lazar C, Branza-Nichita N. N-glycosylation and N-glycan processing in HBV biology and pathogenesis. Cells. 2020;9(6):1404.","journal-title":"Cells"},{"issue":"5","key":"1251_CR99","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1073\/pnas.94.5.1834","volume":"94","author":"MP Marzolo","year":"1997","unstructured":"Marzolo MP, Bull P, Gonz\u00e1lez A. Apical sorting of hepatitis B surface antigen (HBsAg) is independent of N-glycosylation and glycosylphosphatidylinositol-anchored protein segregation. Proc Natl Acad Sci U S A. 1997;94(5):1834\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1251_CR100","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4615-5383-0_19","volume-title":"Glycoimmunology 2","author":"A Mehta","year":"1998","unstructured":"Mehta A, Block TM, Dwek RA. The Role of N-Linked Glycosylation in the Secretion of Hepatitis B Virus. In: Axford JS, editor. Glycoimmunology 2. US, Boston, MA: Springer; 1998. p. 195\u2013205."},{"issue":"5","key":"1251_CR101","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/095632020601700503","volume":"17","author":"E Simsek","year":"2006","unstructured":"Simsek E, Lu X, Ouzounov S, Block TM, Mehta AS. \u03b1-glucosidase inhibitors have a prolonged antiviral effect against Hepatitis B Virus through the sustained inhibition of the large and middle envelope glycoproteins. Antivir Chem Chemother. 2006;17(5):259\u201367.","journal-title":"Antivir Chem Chemother"},{"key":"1251_CR102","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.virol.2014.11.019","volume":"476","author":"EE Schirtzinger","year":"2015","unstructured":"Schirtzinger EE, Andrade CC, Devitt N, Ramaraj T, Jacobi JL, Schilkey F, et al. Repertoire of virus-derived small RNAs produced by mosquito and mammalian cells in response to dengue virus infection. Virology. 2015;476:54\u201360.","journal-title":"Virology"},{"issue":"7","key":"1251_CR103","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00705-016-2855-2","volume":"161","author":"F Idris","year":"2016","unstructured":"Idris F, Muharram SH, Diah S. Glycosylation of dengue virus glycoproteins and their interactions with carbohydrate receptors: possible targets for antiviral therapy. Arch Virol. 2016;161(7):1751\u201360.","journal-title":"Arch Virol"},{"key":"1251_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11050959","author":"E Fang","year":"2023","unstructured":"Fang E, Li M, Liu X, Hu K, Liu L, Zhang Z, et al. NS1 protein N-linked glycosylation site affects the virulence and pathogenesis of dengue virus. Vaccines. 2023. https:\/\/doi.org\/10.3390\/vaccines11050959.","journal-title":"Vaccines"},{"issue":"14","key":"1251_CR105","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1128\/JVI.79.14.8698-8706.2005","volume":"79","author":"K Whitby","year":"2005","unstructured":"Whitby K, Pierson Theodore C, Geiss B, Lane K, Engle M, Zhou Y, et al. Castanospermine, a potent inhibitor of Dengue virus infection in vitro and in vivo. J Virol. 2005;79(14):8698\u2013706.","journal-title":"J Virol"},{"issue":"1","key":"1251_CR106","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1128\/JVI.74.1.564-572.2000","volume":"74","author":"M-P Courageot","year":"2000","unstructured":"Courageot M-P, Frenkiel M-P, Duarte Dos Santos C, Deubel V, Despr\u00e8s P. \u03b1-Glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. J Virol. 2000;74(1):564\u201372.","journal-title":"J Virol"},{"key":"1251_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106147","volume":"238","author":"JWJ Kang","year":"2025","unstructured":"Kang JWJ, Chan KWK, Vasudevan SG, Low JG. \u03b1-Glucosidase inhibitors as broad-spectrum antivirals: current knowledge and future prospects. Antivir Res. 2025;238:106147.","journal-title":"Antivir Res"},{"issue":"3","key":"1251_CR108","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.antiviral.2011.10.002","volume":"92","author":"APS Rathore","year":"2011","unstructured":"Rathore APS, Paradkar PN, Watanabe S, Tan KH, Sung C, Connolly JE, et al. Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model. Antivir Res. 2011;92(3):453\u201360.","journal-title":"Antivir Res"},{"issue":"1","key":"1251_CR109","first-page":"1","volume":"2","author":"D Li","year":"2013","unstructured":"Li D. A highly pathogenic new bunyavirus emerged in China. Emerg Microbes Infect. 2013;2(1):1\u20134.","journal-title":"Emerg Microbes Infect"},{"issue":"36","key":"1251_CR110","doi-asserted-by":"publisher","first-page":"E7564","DOI":"10.1073\/pnas.1705176114","volume":"114","author":"Y Wu","year":"2017","unstructured":"Wu Y, Zhu Y, Gao F, Jiao Y, Oladejo BO, Chai Y, et al. Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope. Proc Natl Acad Sci U S A. 2017;114(36):E7564\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1251_CR111","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/21505594.2022.2060464","volume":"13","author":"T Feng","year":"2022","unstructured":"Feng T, Zhang J, Chen Z, Pan W, Chen Z, Yan Y, et al. Glycosylation of viral proteins: implication in virus\u2013host interaction and virulence. Virulence. 2022;13(1):670\u201383.","journal-title":"Virulence"},{"key":"1251_CR112","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.virol.2020.10.006","volume":"556","author":"M Kimura","year":"2021","unstructured":"Kimura M, Egawa K, Ozawa T, Kishi H, Shimojima M, Taniguchi S, et al. Characterization of pseudotyped vesicular stomatitis virus bearing the heartland virus envelope glycoprotein. Virology. 2021;556:124\u201332.","journal-title":"Virology"},{"issue":"1","key":"1251_CR113","doi-asserted-by":"publisher","first-page":"32956","DOI":"10.1038\/srep32956","volume":"6","author":"M Panico","year":"2016","unstructured":"Panico M, Bouch\u00e9 L, Binet D, O\u2019Connor M-J, Rahman D, Pang P-C, et al. Mapping the complete glycoproteome of virion-derived HIV-1 gp120 provides insights into broadly neutralizing antibody binding. Sci Rep. 2016;6(1):32956.","journal-title":"Sci Rep"},{"issue":"2","key":"1251_CR114","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/ilar.42.2.89","volume":"42","author":"BC Tennant","year":"2001","unstructured":"Tennant BC, Gerin JL. The woodchuck model of hepatitis B virus infection. ILAR J. 2001;42(2):89\u2013102.","journal-title":"ILAR J"},{"issue":"12","key":"1251_CR115","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021451","volume":"5","author":"M Roggendorf","year":"2015","unstructured":"Roggendorf M, Kosinska AD, Liu J, Lu M. The woodchuck, a nonprimate model for immunopathogenesis and therapeutic immunomodulation in chronic hepatitis B virus infection. Cold Spring Harb Perspect Med. 2015;5(12):a021451.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"1251_CR116","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1053\/jhep.2001.25103","volume":"33","author":"A Mehta","year":"2001","unstructured":"Mehta A, Carrou\u00e9e S, Conyers B, Jordan R, Butters T, Dwek RA, et al. Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications. Hepatology. 2001;33(6):1488\u201395.","journal-title":"Hepatology"},{"issue":"6","key":"1251_CR117","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1053\/jhep.2001.25354","volume":"33","author":"N Terrault","year":"2001","unstructured":"Terrault N, Ma M. Adding to the Hepatitis B Virus treatment arsenal: \u03b1\u2013glucosidase inhibitor derivatives. Hepatology. 2001;33(6):1544\u20136.","journal-title":"Hepatology"},{"issue":"9","key":"1251_CR118","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/glycob\/cwad041","volume":"33","author":"\u0141F Sobala","year":"2023","unstructured":"Sobala \u0141F. Evolution and phylogenetic distribution of endo-\u03b1-mannosidase. Glycobiology. 2023;33(9):687\u201399.","journal-title":"Glycobiology"},{"issue":"22","key":"1251_CR119","doi-asserted-by":"publisher","first-page":"13104","DOI":"10.1016\/S0021-9258(19)38272-9","volume":"265","author":"SE Moore","year":"1990","unstructured":"Moore SE, Spiro RG. Demonstration that Golgi endo-alpha-D-mannosidase provides a glucosidase-independent pathway for the formation of complex N-linked oligosaccharides of glycoproteins. J Biol Chem. 1990;265(22):13104\u201312.","journal-title":"J Biol Chem"},{"issue":"17","key":"1251_CR120","doi-asserted-by":"publisher","first-page":"17158","DOI":"10.1074\/jbc.M312144200","volume":"279","author":"KD Tardif","year":"2004","unstructured":"Tardif KD, Mori K, Kaufman RJ, Siddiqui A. Hepatitis C Virus Suppresses the IRE1-XBP1 Pathway of the Unfolded Protein Response. J Biol Chem. 2004;279(17):17158\u201364.","journal-title":"J Biol Chem"},{"issue":"3","key":"1251_CR121","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1042\/BST20200505","volume":"48","author":"SJ Williams","year":"2020","unstructured":"Williams SJ, Goddard-Borger ED. \u0391-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19. Biochem Soc Trans. 2020;48(3):1287\u201395.","journal-title":"Biochem Soc Trans"},{"issue":"7","key":"1251_CR122","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41556-025-01690-1","volume":"27","author":"HH Wang","year":"2025","unstructured":"Wang HH, Biunno I, Sun S, Qi L. SEL1L\u2013HRD1-mediated ERAD in mammals. Nat Cell Biol. 2025;27(7):1063\u201373.","journal-title":"Nat Cell Biol"},{"key":"1251_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105416","volume":"207","author":"I Rodrigo","year":"2022","unstructured":"Rodrigo I, Ballesta C, Nunes EB, P\u00e9rez P, Garc\u00eda-Arriaza J, Arias A. Eeyarestatin I, an inhibitor of the valosin-containing protein, exhibits potent virucidal activity against the flaviviruses. Antivir Res. 2022;207:105416.","journal-title":"Antivir Res"},{"issue":"8","key":"1251_CR124","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","volume":"14","author":"JG Low","year":"2014","unstructured":"Low JG, Sung C, Wijaya L, Wei Y, Rathore APS, Watanabe S, et al. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect Dis. 2014;14(8):706\u201315.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1251_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108354","volume":"301","author":"B Adhikari","year":"2025","unstructured":"Adhikari B, Verchot J, Brandizzi F, Ko DK. ER stress and viral defense: advances and future perspectives on plant unfolded protein response in pathogenesis. J Biol Chem. 2025;301(4):108354.","journal-title":"J Biol Chem"},{"key":"1251_CR126","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.virusres.2014.09.016","volume":"194","author":"TS Fung","year":"2014","unstructured":"Fung TS, Huang M, Liu DX. Coronavirus-induced ER stress response and its involvement in regulation of coronavirus\u2013host interactions. Virus Res. 2014;194:110\u201323.","journal-title":"Virus Res"},{"issue":"36","key":"1251_CR127","doi-asserted-by":"publisher","first-page":"22184","DOI":"10.1074\/jbc.M115.675207","volume":"290","author":"T Zhou","year":"2015","unstructured":"Zhou T, Frabutt DA, Moremen KW, Zheng Y-H. ERManI (Endoplasmic reticulum class I \u03b1-mannosidase) is required for HIV-1 envelope glycoprotein degradation via endoplasmic reticulum-associated protein degradation pathway. J Biol Chem. 2015;290(36):22184\u201392.","journal-title":"J Biol Chem"},{"issue":"6","key":"1251_CR128","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1128\/JVI.03286-13","volume":"88","author":"T Zhou","year":"2014","unstructured":"Zhou T, Dang Y, Zheng Y-H. The mitochondrial translocator protein, TSPO, inhibits HIV-1 envelope glycoprotein biosynthesis via the endoplasmic reticulum-associated protein degradation pathway. J Virol. 2014;88(6):3474\u201384.","journal-title":"J Virol"},{"issue":"1","key":"1251_CR129","doi-asserted-by":"publisher","first-page":"2400292","DOI":"10.1002\/adtp.202400292","volume":"8","author":"L Pradhan","year":"2025","unstructured":"Pradhan L, Manna S, Pragya P, Mukherjee S. Recent therapeutic advancements for Gaucher disease. Adv Ther. 2025;8(1):2400292.","journal-title":"Adv Ther"},{"issue":"2","key":"1251_CR130","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2147\/TCRM.S6865","volume":"4","author":"C Ficicioglu","year":"2008","unstructured":"Ficicioglu C. Review of miglustat for clinical management in Gaucher disease type 1. Ther Clin Risk Manag. 2008;4(2):425\u201331.","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"1251_CR131","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ajh.20504","volume":"80","author":"NJ Weinreb","year":"2005","unstructured":"Weinreb NJ, Barranger JA, Charrow J, Grabowski GA, Mankin HJ, Mistry P. Guidance on the use of miglustat for treating patients with type 1 Gaucher disease. Am J Hematol. 2005;80(3):223\u20139.","journal-title":"Am J Hematol"},{"issue":"1","key":"1251_CR132","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ymgme.2021.06.011","volume":"134","author":"BK Burton","year":"2021","unstructured":"Burton BK, Ellis AG, Orr B, Chatlani S, Yoon K, Shoaff JR, et al. Estimating the prevalence of Niemann-Pick disease type C (NPC) in the United States. Mol Genet Metab. 2021;134(1):182\u20137.","journal-title":"Mol Genet Metab"},{"key":"1251_CR133","doi-asserted-by":"crossref","unstructured":"S. Rajasekharan, R.M. Bonotto, Y. Kazungu, L.N. Alves, M. Poggianella, P.M. Orellana, N. Skoko, S. Polez, A. Marcello, Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2, bioRxiv (2020) 101691.","DOI":"10.1101\/2020.05.18.101691"},{"issue":"11","key":"1251_CR134","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/14656566.2023.2215386","volume":"24","author":"T Bremova-Ertl","year":"2023","unstructured":"Bremova-Ertl T, Schneider S. Current advancements in therapy for Niemann-pick disease: progress and pitfalls. Expert Opin Pharmacother. 2023;24(11):1229\u201347.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"1251_CR135","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10545-011-9368-7","volume":"34","author":"N Belmatoug","year":"2011","unstructured":"Belmatoug N, Burlina A, Giraldo P, Hendriksz CJ, Kuter DJ, Mengel E, et al. Gastrointestinal disturbances and their management in miglustat-treated patients. J Inherit Metab Dis. 2011;34(5):991\u20131001.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"1251_CR136","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/GIM.0b013e3181a1b5c5","volume":"11","author":"BE Shapiro","year":"2009","unstructured":"Shapiro BE, Pastores GM, Gianutsos J, Luzy C, Kolodny EH. Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment. Genet Med. 2009;11(6):425\u201333.","journal-title":"Genet Med"},{"issue":"3","key":"1251_CR137","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10545-010-9193-4","volume":"33","author":"H Champion","year":"2010","unstructured":"Champion H, Ramaswami U, Imrie J, Lachmann RH, Gallagher J, Cox TM, et al. Dietary modifications in patients receiving miglustat. J Inherit Metab Dis. 2010;33(3):379\u201383.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"1251_CR138","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/glycob\/cwaa091","volume":"31","author":"EC Clarke","year":"2021","unstructured":"Clarke EC, Nofchissey RA, Ye C, Bradfute SB. The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication. Glycobiology. 2021;31(4):378\u201384.","journal-title":"Glycobiology"},{"issue":"8","key":"1251_CR139","first-page":"860","volume":"10","author":"D Durantel","year":"2009","unstructured":"Durantel D. Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection. Curr Opin Investig Drugs. 2009;10(8):860\u201370.","journal-title":"Curr Opin Investig Drugs"},{"key":"1251_CR140","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.antiviral.2015.12.008","volume":"127","author":"S Watanabe","year":"2016","unstructured":"Watanabe S, Chan KW-K, Dow G, Ooi EE, Low JG, Vasudevan SG. Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: the search for a window for potential therapeutic efficacy. Antivir Res. 2016;127:10\u20139.","journal-title":"Antivir Res"},{"issue":"5","key":"1251_CR141","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1086\/511310","volume":"195","author":"W Schul","year":"2007","unstructured":"Schul W, Liu W, Xu H-Y, Flamand M, Vasudevan SG. A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J Infect Dis. 2007;195(5):665\u201374.","journal-title":"J Infect Dis"},{"issue":"22","key":"1251_CR142","doi-asserted-by":"publisher","first-page":"14504","DOI":"10.1016\/S0021-9258(18)98715-6","volume":"266","author":"A Tan","year":"1991","unstructured":"Tan A, van den Broek L, van Boeckel S, Ploegh H, Bolscher J. Chemical modification of the glucosidase inhibitor 1-deoxynojirimycin. Structure-activity relationships. J Biol Chem. 1991;266(22):14504\u201310.","journal-title":"J Biol Chem"},{"issue":"5","key":"1251_CR143","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/095632020201300505","volume":"13","author":"A Mehta","year":"2002","unstructured":"Mehta A, Ouzounov S, Jordan R, Simsek E, Lu X, Moriarty RM, et al. Imino sugars that are less toxic but more potent as antivirals, in vitro, compared with N-n-nonyl DNJ. Antivir Chem Chemother. 2002;13(5):299\u2013304.","journal-title":"Antivir Chem Chemother"},{"issue":"21","key":"1251_CR144","doi-asserted-by":"publisher","first-page":"11878","DOI":"10.1073\/pnas.96.21.11878","volume":"96","author":"N Zitzmann","year":"1999","unstructured":"Zitzmann N, Mehta AS, Carrou\u00e9e S, Butters TD, Platt FM, McCauley J, et al. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc Natl Acad Sci U S A. 1999;96(21):11878\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1251_CR145","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13659-024-00477-5","volume":"14","author":"Q Liu","year":"2024","unstructured":"Liu Q, Liu Y, Liu T, Fan J, Xia Z, Zhou Y, et al. Expanding horizons of iminosugars as broad-spectrum anti-virals: mechanism, efficacy and novel developments. Nat Prod Bioprospect. 2024;14(1):55.","journal-title":"Nat Prod Bioprospect"},{"issue":"16","key":"1251_CR146","doi-asserted-by":"publisher","first-page":"14586","DOI":"10.1021\/acs.jmedchem.4c01402","volume":"67","author":"JE Pero","year":"2024","unstructured":"Pero JE, Mueller EA, Adams AM, Adolph RS, Bagchi P, Balce D, et al. Discovery of potent STT3A\/B inhibitors and assessment of their multipathogen antiviral potential and safety. J Med Chem. 2024;67(16):14586\u2013608.","journal-title":"J Med Chem"},{"issue":"10","key":"1251_CR147","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.chembiol.2018.07.005","volume":"25","author":"N Rinis","year":"2018","unstructured":"Rinis N, Golden JE, Marceau CD, Carette JE, Van Zandt MC, Gilmore R, et al. Editing N-glycan site occupancy with small-molecule oligosaccharyltransferase inhibitors. Cell Chem Biol. 2018;25(10):1231-1241.e4.","journal-title":"Cell Chem Biol"},{"key":"1251_CR148","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.antiviral.2017.12.008","volume":"150","author":"J Ma","year":"2018","unstructured":"Ma J, Zhang X, Soloveva V, Warren T, Guo F, Wu S, et al. Enhancing the antiviral potency of ER \u03b1-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo. Antivir Res. 2018;150:112\u201322.","journal-title":"Antivir Res"},{"issue":"5","key":"1251_CR149","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1128\/AAC.01181-07","volume":"52","author":"D Woodhouse Stephen","year":"2008","unstructured":"Woodhouse Stephen D, Smith C, Michelet M, Branza-Nichita N, Hussey M, Dwek Raymond A, et al. Iminosugars in combination with interferon and ribavirin permanently eradicate noncytopathic bovine viral diarrhea virus from persistently infected cells. Antimicrob Agents Chemother. 2008;52(5):1820\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1251_CR150","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/095632020401500304","volume":"15","author":"K Whitby","year":"2004","unstructured":"Whitby K, Taylor D, Patel D, Ahmed P, Tyms AS. Action of Celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C. Antivir Chem Chemother. 2004;15(3):141\u201351.","journal-title":"Antivir Chem Chemother"},{"issue":"1","key":"1251_CR151","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.antiviral.2010.11.002","volume":"89","author":"J Chang","year":"2011","unstructured":"Chang J, Schul W, Butters TD, Yip A, Liu B, Goh A, et al. Combination of \u03b1-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo. Antiviral Res. 2011;89(1):26\u201334.","journal-title":"Antiviral Res"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01251-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-025-01251-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01251-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:03:07Z","timestamp":1762844587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-025-01251-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":151,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1007\/s40121-025-01251-x","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dan Wang, Zihao He and Zehong Chen declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}